Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets

Yuan, 2022, Signal pathways and precision therapy of small-cell lung cancer, Signal Transduct. Targeted Ther., 7, 187, 10.1038/s41392-022-01013-y Siegel, 2022, Cancer statistics, 2022, CA A Cancer J. Clin., 72, 7, 10.3322/caac.21708 Pope, 2002, Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution, JAMA, 287, 1132, 10.1001/jama.287.9.1132 Massagué, 2008, TGFbeta in cancer, Cell, 134, 215, 10.1016/j.cell.2008.07.001 Moses, 2016, The discovery and early days of TGF-β: a historical perspective, Cold Spring Harbor Perspect. Biol., 8, 10.1101/cshperspect.a021865 Massagué, 1998, TGF-beta signal transduction, Annu. Rev. Biochem., 67, 753, 10.1146/annurev.biochem.67.1.753 Kato, 2002, A component of the ARC/Mediator complex required for TGF beta/Nodal signalling, Nature, 418, 641, 10.1038/nature00969 Zhao, 2018, The role of TGF-β/SMAD4 signaling in cancer, Int. J. Biol. Sci., 14, 111, 10.7150/ijbs.23230 Bhowmick, 2004, TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia, Science, 303, 848, 10.1126/science.1090922 Lai, 2020, MiRNAs and LncRNAs: dual roles in TGF-β signaling-regulated metastasis in lung cancer, Int. J. Mol. Sci., 21, 1193, 10.3390/ijms21041193 Cheng, 2015, Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives, Tumour Biol, 36, 479, 10.1007/s13277-015-3093-z Ghafouri-Fard, 2022, miR-1908: a microRNA with diverse functions in cancers and non-malignant conditions, Cancer Cell Int., 22, 281, 10.1186/s12935-022-02709-5 Zhu, 2021, Frontiers of MicroRNA signature in non-small cell lung cancer, Front. Cell Dev. Biol., 9 Lin, 2016, MicroRNA-21 regulates non-small cell lung cancer cell invasion and chemo-sensitivity through SMAD7, Cell. Physiol. Biochem., 38, 2152, 10.1159/000445571 Chae, 2017, MIR‐27a regulates the TGF‐β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer, Mol. Carcinog., 56, 1992, 10.1002/mc.22655 Gu, 2022, Pseudogene MSTO2P interacts with miR-128-3p to regulate coptisine sensitivity of non-small-cell lung cancer (NSCLC) through TGF-β signaling and VEGFC, Journal of Oncology, 10.1155/2022/9864411 Shen, 2020, MiR‐133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF‐β/Smad3 signaling pathway, Thoracic Cancer, 11, 3473, 10.1111/1759-7714.13678 Zhang, 2020, LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway, Eur. Rev. Med. Pharmacol. Sci., 24, 8483 Liu, 2015, miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer, Acta Biochim. Biophys. Sin., 47, 431, 10.1093/abbs/gmv032 Zhu, 2014, Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer, PLoS One, 9 Kudinov, 2016, Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis, Proc. Natl. Acad. Sci. USA, 113, 6955, 10.1073/pnas.1513616113 Yingling, 2004, Development of TGF-β signalling inhibitors for cancer therapy, Nat. Rev. Drug Discov., 3, 1011, 10.1038/nrd1580 Sousa, 2022, Gold nanoconjugates for miRNA modulation in cancer therapy: from miRNA silencing to miRNA mimics, ACS Materials Au, 2, 626, 10.1021/acsmaterialsau.2c00042 Hong, 2020, In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor, PLoS Genet., 16, 10.1371/journal.pgen.1009168 Matsuyama, 2019, Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis, Int. J. Mol. Sci., 21, 132, 10.3390/ijms21010132 Saliminejad, 2019, An overview of microRNAs: biology, functions, therapeutics, and analysis methods, J. Cell. Physiol., 234, 5451, 10.1002/jcp.27486 Pong, 2018, Noncanonical functions of micro RNA pathway enzymes–Drosha, DGCR 8, Dicer and Ago proteins, FEBS Lett., 592, 2973, 10.1002/1873-3468.13196 Jouravleva, 2022, Structural basis of microRNA biogenesis by Dicer-1 and its partner protein Loqs-PB, Mol. Cell, 82, 4049, 10.1016/j.molcel.2022.09.002 Moreno-Moya, 2014, MicroRNA: key gene expression regulators, Fertil. Steril., 101, 1516, 10.1016/j.fertnstert.2013.10.042 Silva-Llanes, 2023, The transcription factor NRF2 has epigenetic regulatory functions modulating HDACs, DNMTs, and miRNA biogenesis, Antioxidants, 12, 641, 10.3390/antiox12030641 Van Kouwenhove, 2011, MicroRNA regulation by RNA-binding proteins and its implications for cancer, Nat. Rev. Cancer, 11, 644, 10.1038/nrc3107 Blobe, 2000, Role of transforming growth factor beta in human disease, N. Engl. J. Med., 342, 1350, 10.1056/NEJM200005043421807 Tian, 2011, Transforming growth factor-β and the hallmarks of cancer, Cell. Signal., 23, 951, 10.1016/j.cellsig.2010.10.015 Baba, 2022, Transforming growth factor-beta (TGF-β) signaling in cancer-A betrayal within, Front. Pharmacol., 13, 791272, 10.3389/fphar.2022.791272 Derynck, 2021, TGFβ biology in cancer progression and immunotherapy, Nat. Rev. Clin. Oncol., 18, 9, 10.1038/s41571-020-0403-1 Paola, 2017, TGF-Β activation and signaling in angiogenesis Pardali, 2007, Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer, Biochim. Biophys. Acta, 1775, 21 Huang, 2016, Dichotomous roles of TGF-β in human cancer, Biochem. Soc. Trans., 44, 1441, 10.1042/BST20160065 Yoshimatsu, 2016, Roles of signaling and transcriptional networks in pathological lymphangiogenesis, Adv. Drug Deliv. Rev., 99, 161, 10.1016/j.addr.2016.01.020 Torre-Amione, 1990, A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance, Proc. Natl. Acad. Sci. U. S. A., 87, 1486, 10.1073/pnas.87.4.1486 Nausch, 2008, NKG2D ligands in tumor immunity, Oncogene, 27, 5944, 10.1038/onc.2008.272 Lee, 2021, Downregulation of NKG2DLs by TGF-β in human lung cancer cells, BMC Immunol., 22, 44, 10.1186/s12865-021-00434-8 Marwitz, 2021, Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer, J Immunother Cancer, 9, 10.1136/jitc-2020-001469 Chen, 2003, Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J. Exp. Med., 198, 1875, 10.1084/jem.20030152 Chen, 2003, TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression, Cytokine Growth Factor Rev., 14, 85, 10.1016/S1359-6101(03)00003-0 Mulé, 1988, Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells, Cancer Immunol. Immunother., 26, 95, 10.1007/BF00205600 Zhang, 2017, TGF-Β family signaling in the control of cell proliferation and survival, Cold Spring Harbor Perspect. Biol., 9, 10.1101/cshperspect.a022145 Tachibana, 1997, Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells, J. Clin. Invest., 99, 2365, 10.1172/JCI119418 Tania, 2014, Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer, Tumour Biol, 35, 7335, 10.1007/s13277-014-2163-y Zhang, 2009, Non-Smad pathways in TGF-β signaling, Cell Res., 19, 128, 10.1038/cr.2008.328 Zhang, 2009, Non-Smad pathways in TGF-beta signaling, Cell Res., 19, 128, 10.1038/cr.2008.328 Haque, 2017, Transforming growth factor-β: a therapeutic target for cancer, Hum. Vaccines Immunother., 13, 1741, 10.1080/21645515.2017.1327107 Oft, 1998, TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis, Curr. Biol., 8, 1243, 10.1016/S0960-9822(07)00533-7 Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Popper, 2016, Progression and metastasis of lung cancer, Cancer Metastasis Rev., 35, 75, 10.1007/s10555-016-9618-0 Baratelli, 2010, PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer, Am J Transl Res, 2, 356 Lai, 2020, MiRNAs and LncRNAs: dual roles in TGF-β signaling-regulated metastasis in lung cancer, Int. J. Mol. Sci., 21, 10.3390/ijms21041193 Mariathasan, 2018, TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells, Nature, 554, 544, 10.1038/nature25501 Hussen, 2021, MicroRNA: a signature for cancer progression, Biomed. Pharmacother., 138, 111528, 10.1016/j.biopha.2021.111528 Häger, 2011, MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors, Blood, 118, 6649, 10.1182/blood-2011-03-339978 Ghafouri-Fard, 2022, A review on the role of miR-149-5p in the carcinogenesis, Int. J. Mol. Sci., 23, 415, 10.3390/ijms23010415 Ghafouri-Fard, 2021, A review on the role of miR-1290 in cell proliferation, apoptosis and invasion, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.763338 Li, 2020, PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-β (TGF-β) signaling in the progression of non-small cell lung carcinoma, Cell Death Dis., 11, 710, 10.1038/s41419-020-02900-4 Cai, 2017, Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC, Nat. Commun., 8, 15870, 10.1038/ncomms15870 Wang, 2017, TGF-β1-induced epithelial–mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin, Cell. Mol. Biol. Lett., 22, 1, 10.1186/s11658-017-0053-1 Li, 2017, MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2, Biomed. Pharmacother., 96, 1170, 10.1016/j.biopha.2017.11.105 Cao, 2012, MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells, Int. J. Oncol., 41, 869, 10.3892/ijo.2012.1535 Li, 2017, miR-181b-5p mediates TGF-β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells, Int. J. Oncol., 51, 158, 10.3892/ijo.2017.4007 Cai, 2017, Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC, Nat. Commun., 8, 15870, 10.1038/ncomms15870 Han, 2017, MiR‐9 is involved in TGF‐β1‐induced lung cancer cell invasion and adhesion by targeting SOX 7, J. Cell Mol. Med., 21, 2000, 10.1111/jcmm.13120 Li, 2017, MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2, Biomed. Pharmacother., 96, 1170, 10.1016/j.biopha.2017.11.105 Kitamura, 2014, MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells, Mol. Cancer Therapeut., 13, 444, 10.1158/1535-7163.MCT-13-0448 Yang, 2019, MiR-1246 promotes metastasis and invasion of A549 cells by targeting GSK-3β‒mediated Wnt/β-catenin pathway, Cancer Res Treat, 51, 1420, 10.4143/crt.2018.638 Rufino‐Palomares, 2013, microRNAs as oncogenes and tumor suppressors, MicroRNAs in medicine, 223, 10.1002/9781118300312.ch14 Zhang, 2016, MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci., 20, 3793 Li, 2019, MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway, Cell Cycle, 18, 1727, 10.1080/15384101.2019.1632135 Jiang, 2019, MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer, J. Cancer, 10, 2735, 10.7150/jca.31800 Bai, 2017, MicroRNA-196b inhibits cell growth and metastasis of lung cancer cells by targeting Runx2, Cell. Physiol. Biochem., 43, 757, 10.1159/000481559 Yin, 2018, miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of non-small cell lung cancer by targeting MTDH, Cancer Cell Int., 18, 1, 10.1186/s12935-018-0601-4 Hu, 2016, MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells, Lung Cancer, 97, 87, 10.1016/j.lungcan.2016.04.017 Zhang, 2016, MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci., 20, 3793 Watt, 2018, MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma, Cell. Signal., 50, 25, 10.1016/j.cellsig.2018.06.008 Wu, 2020, Downregulation of oncogenic gene TGFβR2 by miRNA-107 suppresses non-small cell lung cancer, Pathol. Res. Pract., 216, 152690, 10.1016/j.prp.2019.152690 Chen, 2019, Suppression of non-small cell lung cancer migration and invasion by hsa-miR-486-5p via the TGF-β/SMAD2 signaling pathway, J. Cancer, 10, 6014, 10.7150/jca.35017 Lei, 2014, MiR‐142‐3p represses TGF‐β‐induced growth inhibition through repression of TGFβR1 in non‐small cell lung cancer, Faseb. J., 28, 2696, 10.1096/fj.13-247288 Zu, 2016, The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis, Carcinogenesis, 37, 333, 10.1093/carcin/bgw011 Bai, 2017, MicroRNA-196b inhibits cell growth and metastasis of lung cancer cells by targeting Runx2, Cell. Physiol. Biochem., 43, 757, 10.1159/000481559 Yin, 2018, miR-145 and miR-497 suppress TGF-β-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH, Cancer Cell Int., 18, 105, 10.1186/s12935-018-0601-4 Zhang, 2016, A regulatory loop involving miR-29c and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal transition in lung cancer, Oncotarget, 7, 85905, 10.18632/oncotarget.13137 Zhang, 2017, MiR-22 inhibits lung cancer cell EMT and invasion through targeting Snail, Eur. Rev. Med. Pharmacol. Sci., 21, 3598 Chae, 2019, MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination, Mol. Oncol., 13, 2663, 10.1002/1878-0261.12581 Zhang, 2020, MicroRNA-375 prevents TGF-β-dependent transdifferentiation of lung fibroblasts via the MAP2K6/P38 pathway, Mol. Med. Rep., 22, 1803, 10.3892/mmr.2020.11261 Hussen, 2021, MicroRNAs: important players in breast cancer angiogenesis and therapeutic targets, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.764025 Hong, 2020, Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours, Br. J. Cancer, 122, 1630, 10.1038/s41416-020-0802-1 Fortunato, 2014, Therapeutic use of microRNAs in lung cancer, BioMed Res. Int., 2014, 756975, 10.1155/2014/756975 Akram, 2022, CRISPR/Cas9: a revolutionary genome editing tool for human cancers treatment, Technol. Cancer Res. Treat., 21, 10.1177/15330338221132078 Rasul, 2022, Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Mol. Cancer, 21, 64, 10.1186/s12943-021-01487-4 Shan, 2019, High-fidelity and rapid quantification of miRNA combining crRNA programmability and CRISPR/Cas13a trans-cleavage activity, Anal. Chem., 91, 5278, 10.1021/acs.analchem.9b00073 Hussen, 2023, Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges, Military Medical Research, 10, 32, 10.1186/s40779-023-00468-6 Scagliotti, 2005, Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer, Semin. Oncol., 32, S5, 10.1053/j.seminoncol.2005.02.006 Lin, 2016, MicroRNA-21 regulates non-small cell lung cancer cell invasion and chemo-sensitivity through SMAD7, Cell. Physiol. Biochem., 38, 2152, 10.1159/000445571 Lin, 2009, Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF), Cancer Lett., 285, 127, 10.1016/j.canlet.2009.04.037 Datta, 2013, Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells, J. Cancer Res. Clin. Oncol., 139, 563, 10.1007/s00432-012-1352-6 Viollet, 2012, Cellular and molecular mechanisms of metformin: an overview, Clin. Sci. (Lond.), 122, 253, 10.1042/CS20110386 Li, 2017, Progress in the application and mechanism of metformin in treating non-small cell lung cancer, Oncol. Lett., 13, 2873, 10.3892/ol.2017.5862 Luo, 2017, MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway, Sci. Rep., 7, 43427, 10.1038/srep43427 Sun, 2018, Hypermethylated CD36 gene affected the progression of lung cancer, Gene, 678, 395, 10.1016/j.gene.2018.06.101 Nie, 2014, Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors, Cancer Lett., 354, 12, 10.1016/j.canlet.2014.08.010 Zhang, 2017, Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis, Drug Des. Dev. Ther., 11, 969, 10.2147/DDDT.S129305 Konoshenko, 2022, MicroRNAs as predictors of lung-cancer resistance and sensitivity to cisplatin, Int. J. Mol. Sci., 23, 10.3390/ijms23147594 Wang, 2015, MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC, Sci. Rep., 5, 17618, 10.1038/srep17618 Jiang, 2014, MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC, PLoS One, 9 Osman, 2021, Anti-cancer effects of Tranilast: an update, Biomed. Pharmacother., 141, 111844, 10.1016/j.biopha.2021.111844 Takahashi, 2020, Tranilast inhibits TGF-β1-induced epithelial-mesenchymal transition and invasion/metastasis via the suppression of Smad4 in human lung cancer cell lines, Anticancer Res., 40, 3287, 10.21873/anticanres.14311 Shiozaki, 2020, Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: phase I/II study (TNAC), Medicine (Baltim.), 99 Chuang, 2017, Tranilast inhibits genes functionally involved in cell proliferation, fibrosis, and epigenetic regulation and epigenetically induces miR-29c expression in leiomyoma cells, Reprod. Sci., 24, 1253, 10.1177/1933719116682878 Zhou, 2012, Inhibition of miR-29 by TGF-beta-smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts, PLoS One, 7 Sun, 2018, MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway, Sci. Rep., 8, 8007, 10.1038/s41598-018-26381-w Zhan, 2018, MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA, Mol. Med. Rep., 17, 6705